Related references
Note: Only part of the references are listed.HIV-1 and HTLV-1 Transmission Modes: Mechanisms and Importance for Virus Spread
Svetlana Kalinichenko et al.
VIRUSES-BASEL (2022)
HTLV-1 and Co-infections
Carolina Rosadas et al.
FRONTIERS IN MEDICINE (2022)
Sendai virus particles carrying target virus glycoproteins for antibody induction
Hiroshi Ishii et al.
VACCINE (2022)
Selective APC-targeting of a novel Fc-fusion multi-immunodominant recombinant protein (tTax-tEnv:mFc?a) for HTLV-1 vaccine development
Mina Shafifar et al.
LIFE SCIENCES (2022)
HTLV-1 Infection and Pathogenesis: New Insights from Cellular and Animal Models
Greta Forlani et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Laboratory diagnosis of human T-lymphotropic virus in Brazil: assays, flowcharts, challenges, and perspectives
Adele Caterino-de-Araujo et al.
REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL (2021)
Management of HAM/TSP Systematic Review and Consensus-based Recommendations 2019
Abelardo Araujo et al.
NEUROLOGY-CLINICAL PRACTICE (2021)
Association between HTLV-1 infection and adverse health outcomes: a systematic review and meta-analysis of epidemiological studies
Gill Schierhout et al.
LANCET INFECTIOUS DISEASES (2020)
Diagnostic Approaches and Established Treatments for Adult T Cell Leukemia Lymphoma
Kunihiro Tsukasaki et al.
FRONTIERS IN MICROBIOLOGY (2020)
Human T-lymphotropic virus type 1 (HTLV-1) and cellular immune response in HTLV-1-associated myelopathy/tropical spastic paraparesis
Satoshi Nozuma et al.
JOURNAL OF NEUROVIROLOGY (2020)
Development and Applications of Viral Vectored Vaccines to Combat Zoonotic and Emerging Public Health Threats
Sophia M. Vrba et al.
VACCINES (2020)
Human T-Cell Lymphotropic Virus Type 1 and associated diseases in Latin America
Emiliana Eusebio-Ponce et al.
TROPICAL MEDICINE & INTERNATIONAL HEALTH (2019)
Immunovirological markers in HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP)
Yoshimi Enose-Akahata et al.
RETROVIROLOGY (2019)
Combinatorial screening algorithm to engineer multiepitope subunit vaccine targeting human T-lymphotropic virus-1 infection
Rajan K. Pandey et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
HTLV-1 infection of myeloid cells: from transmission to immune alterations
Brenda Rocamonde et al.
RETROVIROLOGY (2019)
Vaccinia virus-mediated cancer immunotherapy: cancer vaccines and oncolytics
Zong Sheng Guo et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Predicting and Designing Epitope Ensemble Vaccines against HTLV-1
Saruar Alam et al.
JOURNAL OF INTEGRATIVE BIOINFORMATICS (2019)
HTLV-1, the Other Pathogenic Yet Neglected Human Retrovirus: From Transmission to Therapeutic Treatment
Nicolas Futsch et al.
VIRUSES-BASEL (2018)
Immune Responses to Retroviruses
Asier Saez-Cirion et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 36 (2018)
The CD8 T Cell Response to Respiratory Virus Infections
Megan E. Schmidt et al.
FRONTIERS IN IMMUNOLOGY (2018)
The novel immunogenic chimeric peptide vaccine to elicit potent cellular and mucosal immune responses against HTLV-1
Mona Kabiri et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2018)
Robust mucosal and systemic responses against HTLV-1 by delivery of multiepitope vaccine in PLGA nanoparticles
Mona Kabiri et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2018)
First-in-Human Evaluation of the Safety and Immunogenicity of an Intranasally Administered Replication-Competent Sendai Virus-Vectored HIV Type 1 Gag Vaccine: Induction of Potent T-Cell or Antibody Responses in Prime-Boost Regimens
Julien Nyombayire et al.
JOURNAL OF INFECTIOUS DISEASES (2017)
Dendritic cell maturation, but not type I interferon exposure, restricts infection by HTLV-1, and viral transmission to T-cells
Gerges Rizkallah et al.
PLOS PATHOGENS (2017)
Immunization against HTLV-I with chitosan and tri-methylchitosan nanoparticles loaded with recombinant env23 and env13 antigens of envelope protein gp46
Maryam Amirnasr et al.
MICROBIAL PATHOGENESIS (2016)
Protective effect of cytotoxic T lymphocytes targeting HTLV-1 bZIP factor
Kenji Sugata et al.
BLOOD (2015)
Clinical outcomes of a novel therapeutic vaccine with Tax peptide-pulsed dendritic cells for adult T cell leukaemia/lymphoma in a pilot study
Youko Suehiro et al.
BRITISH JOURNAL OF HAEMATOLOGY (2015)
Combined Cytolytic Effects of a Vaccinia Virus Encoding a Single Chain Trimer of MHC-I with a Tax-Epitope and Tax-Specific CTLs on HTLV-I-Infected Cells in a Rat Model
Takashi Ohashi et al.
BIOMED RESEARCH INTERNATIONAL (2014)
Modern Subunit Vaccines: Development, Components, and Research Opportunities
Peter Michael Moyle et al.
CHEMMEDCHEM (2013)
Pre-existing immunity against vaccine vectors - friend or foe?
Manvendra Saxena et al.
MICROBIOLOGY-SGM (2013)
Clinical development of Modified Vaccinia virus Ankara vaccines
Sarah C. Gilbert
VACCINE (2013)
Modified Vaccinia virus Ankara: Innate immune activation and induction of cellular signalling
Philip J. R. Price et al.
VACCINE (2013)
Cellular factors involved in HTLV-1 entry and pathogenicity
Hiroo Hoshino
FRONTIERS IN MICROBIOLOGY (2012)
Epidemiological aspects and world distribution of HTLV-1 infection
Antoine Gessain et al.
FRONTIERS IN MICROBIOLOGY (2012)
Current status of HTLV-1 infection
Toshiki Watanabe
INTERNATIONAL JOURNAL OF HEMATOLOGY (2011)
HTLV-1 and the Host Immune System : How the Virus Disrupts Immune Regulation, Leading to HTLV-1 Associated Diseases
Yorifumi Satou et al.
JOURNAL OF CLINICAL AND EXPERIMENTAL HEMATOPATHOLOGY (2010)
Conformation-specific antibodies targeting the trimer-of-hairpins motif of the human T-cell leukemia virus type 1 transmembrane glycoprotein recognize the viral envelope but fail to neutralize viral entry
Antonis Mirsaliotis et al.
JOURNAL OF VIROLOGY (2007)
Chimeric peptide vaccine composed of B- and T-cell epitopes of human T-cell leukemia virus type 1 induces humoral and cellular immune responses and reduces the proviral load in immunized squirrel monkeys (Saimiri sciureus)
M Kazanji et al.
JOURNAL OF GENERAL VIROLOGY (2006)
Pathogen recognition and innate immunity
S Akira et al.
CELL (2006)
HTLV-I basic leucine zipper factor gene mRNA supports proliferation of adult T cell leukemia cells
Y Satou et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
De novo design of peptide Immunogens that mimic the coiled coil region of human T-cell leukemia virus type-1 glycoprotein 21 transmembrane subunit for induction of native protein reactive neutralizing antibodies
R Sundaram et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Protective efficacy of multiepitope human leukocyte antigen-A*0201 restricted cytotoxic T-lymphocyte peptide construct against challenge with human T-cell lymphotropic virus type 1 Tax recombinant vaccinia virus
R Sundaram et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2004)
A novel multivalent human CTL peptide construct elicits robust cellular immune responses in HLA-A*0201 transgenic mice: implications for HTLV-1 vaccine design
R Sundaram et al.
VACCINE (2003)
Covalent trimers of the internal N-terminal trimeric coiled-coil of gp41 and antibodies directed against them are potent inhibitors of HIV envelope-mediated cell fusion
JM Louis et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Subunit protein vaccines: Theoretical and practical considerations for HIV-1
MW Cho
CURRENT MOLECULAR MEDICINE (2003)
Spread of HTLV-I between lymphocytes by virus-induced polarization of the cytoskeleton
T Igakura et al.
SCIENCE (2003)
New approach for generation of neutralizing antibody against human T-cell leukaemia virus type-I (HTLV-I) using phage clones
N Begum et al.
VACCINE (2002)
Immunogenicity and protective efficacy of recombinant human T-cell leukemia/lymphoma virus type 1 NYVAC and naked DNA vaccine candidates in squirrel monkeys (Saimiri sciureus)
M Kazanji et al.
JOURNAL OF VIROLOGY (2001)
Enhanced immunogenicity of a conformational epitope of human T-lymphotropic virus type 1 using a novel chimeric peptide
M Frangione-Beebe et al.
VACCINE (2000)
Share Paper
